Navigation Links
Cerno Bioscience Introduces MassWorks AutoID for Fully Automated Quadrupole MS Formula Determination
Date:2/16/2011

DANBURY, Conn., Feb. 16, 2011 /PRNewswire/ -- Cerno Bioscience today announces the successful test installation and operation of a new software product, MassWorks AutoID™, at a major pharmaceutical company near Boston, MA.  By automating the patented MassWorks calibration and formula ID process on the widely available quadrupole MS systems, AutoID makes the 100x improvement in mass accuracy and the unparallel Spectral Accuracy available seamlessly and at all times.  With both accurate mass and high Spectral Accuracy, AutoID allows any user to either confirm a given formula or propose possible formulas in a fully automated fashion without any human intervention or manual operation.

Built on top of its award-winning MassWorks software, AutoID completely removes the manual steps involved in MassWorks, such as the injection of a calibration standard, the user selection of ions and parameters for elemental composition determination, and the report generation/delivery.  For highly automated applications such as Open Access, AutoID not only brings the formula ID capability to non-expert MS users including synthetic organic or medicinal chemists but also reduces the burden of analytical chemists or mass spectrometrists supporting these functions.

Mr. Hongliang (Leo) Xu, Software Development Manager comments: "The AutoID project is our very first effort at taking the modular components from MassWorks to build new and dedicated applications.  We succeeded by completing this first installation in record time and thus paved the way for more exciting new products to come."  Dr. Yongdong Wang, President of Cerno Bioscience adds: "We built MassWorks with expert MS users in mind and have been very successful at marketing it to hundred of these users around the world.  By making the formula ID capability available seamlessly to non-expert users on a quadrupole system, we can realize significant savings in time, effort, and hardware expenditure for our customers.  While we will continue to enhance and maintain MassWorks software as an industry-leading research tool, AutoID represents the start of our endeavor at introducing automated and dedicated new products to address the broader market needs.  Our goal is to make MassWorks calibration technology and Spectral Accuracy available to every MS user."

To learn more about the concept of Spectral Accuracy, see this front cover feature article in Analytical Chemistry (http://pubs.acs.org/doi/full/10.1021/ac100888b).

For more information on Cerno Bioscience, MassWorks, or AutoID, please email info@cernobioscience.com, call +1 203-312-1150, or visit www.cernobioscience.com.  

About Cerno BioscienceCerno is dedicated to the practical application of modern mathematical techniques to Mass Spectrometry for the purpose of improving the quality, accuracy and reliability of MS analysis. These techniques can be used to dramatically improve the amount of information obtainable from and reduce the amount of time required of many MS experiments. Cerno's technologies are proprietary and protected through numerous patents granted and submitted world-wide. For more information on Cerno MS technologies, applications, or products please visit our Web site: www.cernobioscience.com.

About Cerno Bioscience ProductsCerno Bioscience's MassWorks family of software products performs post-acquisition MS calibration and formula determination through either CLIPS at unit mass resolution or sCLIPS at higher resolution.  It supports all major MS vendor data formats and works with all MS instruments including GC/MS, LC/MS, TOF, qTOF, and FT MS. Cerno Bioscience products are used in major R&D labs for pharmaceuticals, food, beverages, flavors, fragrances, natural products, environmental analysis, forensics, fine chemicals and petrochemicals. For more information, please visit: http://www.cernobioscience.com/products.html.

Copyright 2011. Cerno Bioscience LLC. All rights reserved. Cerno Bioscience is a registered trademark and MassWorks, CLIPS, and sCLIPS are trademarks of Cerno Bioscience.  Media Contact:Yongdong WangCerno Bioscience+1 203-312-1151pr@cernobioscience.com
'/>"/>

SOURCE Cerno Bioscience
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results
2. YM BioSciences Reports Fiscal Second Quarter 2011 Operational and Financial Results
3. Sangamo BioSciences Reports Fourth Quarter and Full Year 2010 Financial Results
4. Sangamo BioSciences Announces Fourth Quarter and Full Year 2010 Conference Call and Webcast
5. Centroid Wins a 2-Year Infrastructure Outsourcing Services Contract with eBioscience
6. YM BioSciences Announces Data from Nimotuzumab Phase II Gastric Cancer Trial Reported at ASCO GI Symposium
7. Ardea Biosciences Prices Public Offering of Common Stock
8. Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients
9. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
10. Whitney M. Young, Jr. Health Services and Magellan Biosciences Partner to Provide Three-Minute LeadCare II Blood-Lead Screenings to Berlin Elementary Students
11. YM BioSciences Closes Public Offering of Common Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... Jan. 16, 2017   Valentin A. Pavlov, PhD ... , president and CEO of The Feinstein Institute ... analysis of how the nervous system regulates the immune ... bioelectronic medicine devices to treat disease and ... Neuroscience . The paper examines various studies ...
(Date:1/16/2017)... , Jan. 16, 2017  Eurofins Genomics today ... will allow more customers to receive their primers in ... or compromise in quality found with other providers. Express ... United States at no additional fee. ... routine genetic studies, including DNA sequencing, genotyping, site-directed mutagenesis, ...
(Date:1/14/2017)... 13, 2017  The Alliance for Safe Biologic Medicines ... FDA final guidance on biologic naming: ... in emphasizing the importance of distinct naming for all ... the benefits biosimilars will bring to patients, including new ... the portion of the Guidance dealing with suffix design ...
(Date:1/13/2017)... and Markets has announced the addition of the "Global Biopolymers Market ... ... 16.83% during the period 2017-2021. The report covers the ... 2017-2021. To calculate the market size, the report considers the revenue generated ... a a discussion of the key vendors operating in this market. ...
Breaking Biology Technology:
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
(Date:12/15/2016)... 2016  There is much more to innovative access ... engine. Continental will demonstrate the intelligence of today,s solutions ... . Through the combination of the keyless entry and ... elements, the international technology company is opening up new ... "The integration of biometric elements brings our ...
(Date:12/8/2016)... 2016 Market Research Future published a half cooked research ... Biometric Security and Service Market is expected to grow over the ... Market Highlights: ... Mobile Biometric Security and Service Market ... need of authentication and security from unwanted cyber threats. The increasing ...
Breaking Biology News(10 mins):